|
HY-100007-100mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100007-250mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100233-10mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-100mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-25mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-5mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100233-50mg
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-100302-1mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-10mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-100mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-25mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-5mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100302-50mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-100303-1mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100303-10mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100303-100mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100303-25mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100303-5mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100303-50mg
|
MedChemexpress LLC
|
FR194738 free base [CAS 204067-45-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100304-1mg
|
MedChemexpress LLC
|
KW-8232 free base [CAS 170365-25-0]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-100401-10mg
|
MedChemexpress LLC
|
Pactimibe [CAS 189198-30-9]
|
|
Neuroscience-Neuromodulation
|
|
